Bekaert to Invest in Russian Steel Cord Production Plant

To strengthen its existing position in Russia, Bekaert intends to invest in a new steel cord production plant in the Lipetsk Special Economic Zone. This investment of more than € 97 million will take place in phases over the period 2008–2013. The first phase is scheduled to enter production in 2010.

Bekaert’s commitment will be underlined by the presence later this month of a delegation headed by Chairman Baron Paul Buysse and CEO Bert De Graeve at an official inaugural event for new investors in the Lipetsk region, which will also be attended by high-level Russian officials.

With this new investment, Bekaert is responding to the rising local demand for steel cord products for tire reinforcement generated by Russia’s rapid economic growth. The Lipetsk region, about 400 kilometers south of Moscow, is strategically located close to the target markets, with good logistics, good access to energy supplies and a skilled labor force.

Bekaert already has a portfolio of customers in Russia for steel cord products for tire reinforcement, steel fibers for concrete reinforcement and other specialized wire products. Bekaert’s Russian customers are currently being supplied by its plants in Central Europe.

Baron Paul Buysse, Chairman of Bekaert’s Board of Directors, commented: “Expanding our position in Russia is entirely consistent with Bekaert’s strategy of sustainable profitable growth. The decision to set up our own production platform in Russia is proof of Bekaert’s faith in the long-term potential of this country. Local production will enable Bekaert effectively to meet the rapidly growing demand for top-quality products.”

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.